ALTO FY2023 SEC EDGAR DEF 14A

Alto Ingredients, Inc. CEO pay ratio

The CEO earned $1.2M in FY2023 against median worker pay of $84,084 · Chemicals & Pharmaceuticals.

State
DE
Filing date
2024-04-26
Industry
Chemicals & Pharmaceuticals
Fiscal year
FY2023

Data updated August 2026

Subscribe to Alto Ingredients, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
6:1
Below Average (Scale: 0–1000:1)
CEO pay
$1.2M
Median worker
$84,084

Latest filing FY2023. This company's newest DEF 14A on file is for FY2023, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.

Answer first

Alto Ingredients, Inc. reported a 6:1 CEO-to-worker pay ratio in FY2023 - at or below the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.

Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Pay ratio
6:1
FY2023 disclosed
CEO total
$1.2M
Summary Compensation Table total
Median worker
$84,084
Dodd-Frank median employee

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2023

A component-level pay breakdown is not reported in Alto Ingredients, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Alto Ingredients, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2023. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
6:1
FY2023
vs prior FY
+4:1
from FY2022 2:1
CEO $ YoY
-18%
$1.2M latest
Filings shown
3
FY2021–2023
Alto Ingredients, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $1.9M - $80,677 3:1 -
2022 $1.5M -21% $82,011 2:1 -1:1
2023 $1.2M -18% $84,084 6:1 +4:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 778164, FY2021–2023. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
6:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$1.2M
Companies in Industry
168
vs. Industry Median
Below

Alto Ingredients, Inc.: near-parity Item 402(u) ratio

Alto Ingredients, Inc. stamps FLOOR · HIGH-MED at 6:1 against $84,084 median worker pay in FY2023. the CEO earned 6× the median employee ($84,084) in FY2023.

At $84,084 median worker pay, the FLOOR stamp is near pay-parity territory under LIGHT CEO total.

CEO Total Pay

$1.2M

FY2023 Summary Compensation, below median

Pay Ratio

6:1

Below typical

What FY2023 shows for Alto Ingredients, Inc.

Alto Ingredients, Inc. stamps FLOOR · HIGH-MED at 6:1 against $84,084 median worker pay in FY2023. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Alto Ingredients, Inc.'s $1.2M CEO total is at or below the $7.9M industry median CEO pay.

Alto Ingredients, Inc. stamps FLOOR · LIGHT · HIGH-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2023

Total Compensation
$1.2M
Median Employee Pay
$84,084
Pay Ratio
6:1
Filing Date
2024-04-26

Company Info

Ticker
ALTO
CIK
778164
Industry
Chemicals & Pharmaceuticals
SIC Code
2860
State
DE
SEC EDGAR DEF 14A for CIK 778164, FY2023. Informational only, not investment advice. Verify on EDGAR.

Read with Alto Ingredients, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · LIGHT · HIGH-MED.

Data sourced from SEC EDGAR DEF 14A for Alto Ingredients, Inc. (CIK 778164), FY2023. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.